The Brien Holden Vision Institute (BHVI) has announced an agreement that will see OCULUS incorporate BHVI’s algorithms for refractive error management into its Myopia Master ophthalmic instructions, developed for the management of myopia.
Using large and expansive datasets generated on our own and in collaboration with our research partners across the globe, the team at BHVI is continually engaged in expanding the state of knowledge
The OCULUS Myopia Master is the world’s first device to combine the measurement methods of myopia management: axial length, refraction values and the central corneal radii.
“Using large and expansive datasets generated on our own and in collaboration with our research partners across the globe, the team at BHVI is continually engaged in expanding the state of knowledge as well as bringing solutions to reverse the rising myopia epidemic,” said Prof Padmaja Sankaridurg, Head, Myopia Program at BHVI.
“We are delighted for the opportunity to work together with leading ophthalmic industry such as OCULUS to translate some of this knowledge.”
Myopia makes seeing distant objects difficult and causes the eyeball to change shape. Around 30% of the world is currently Myopic. Research conducted at BHVI predicts that by 2050, almost 50% of the world’s population will be Myopic.
“Our agreement with OCULUS will see our research translated into more instruments that optometrists can use to manage Myopia, globally,” said Yvette Waddell, BHVI CEO.
Christian Kirchhübel, CEO of OCULUS acknowledged that “Through working with and incorporating BHVI’s unique technology into our Myopia Master suite of offerings, we can continue to deliver world class instruments to our clients.”
OCULUS, BHVI and its collaboration partner, the Shanghai Eye Disease Prevention and Treatment Centre will continue to work together to further develop the functionality of OCULUS’ Myopia Master.
